googlemarker

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 438474.39 Face Value (Rs.) : 1 House : Aurobindo
BSE748.40-14.25 (-1.87 %)
PREV CLOSE (Rs.) 762.65
OPEN PRICE (Rs.) 765.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 748.40 (88)
VOLUME 172413
TODAY'S LOW / HIGH (Rs.)745.00 770.60
52 WK LOW / HIGH (Rs.)504 895
NSE748.95-13.3 (-1.74 %)
PREV CLOSE( Rs. ) 762.25
OPEN PRICE (Rs.) 761.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 748.95 (9174)
VOLUME 2208045
TODAY'S LOW / HIGH(Rs.) 743.40 770.80
52 WK LOW / HIGH (Rs.)503.05 895
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1307.64
Dividend Yield(%)
0.33
TTM EPS (Rs.)
27.70
P/E Ratio
27.02
Book Value (Rs.)
149.24
Face Value (Rs.)
1
MCap (Rs. in Mn)
438474.39
Price/Earning (TTM)
22.81
Price/Sales (TTM)
4.71
Price/Book (MRQ)
5.01
PAT Margin (%)
17.45
ROCE (%)
19.75
Incorporation Year : 26-12 1986

Management Info :

K Ragunathan - Chairman N Govindarajan - Managing Director

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone : +91-040-66725000

Website : www.aurobindo.com

Registrars Details :

Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
01Sep Updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
30Aug Aurobindo Pharma in talks with Shreya
Aurobindo Pharma is reportedly in discussion with Shreya Life Sciences f..
30Aug Aurobindo Pharma rises on talks of buy
Aurobindo Pharma is currently trading at Rs. 740.20, up by 8.75 points o..
QTR Jun 17 ANNUAL 17
Net Profit3073.317067.6
Gross Profit 4066.2 21785.7
Operating Profit 5002.6 25099
Net Sales 21882.9 97812.1
Rs. in Millions
Abbott India (BSE)
img  4171.40 (2.48%)
M.Cap (Rs. in Cr)8863.93
Hester Biosciences (BSE)
img  929.85 (4.37%)
M.Cap (Rs. in Cr)791.01
Divis Lab (BSE)
img  863.85 (3.61%)
M.Cap (Rs. in Cr)22932.50
SMS Lifesciences (BSE)
img  452.30 (4.99%)
M.Cap (Rs. in Cr)136.74
PROMOTERS
51.87%
NON-INSTITUTION
14.32%
MUTUAL FUNDS/UTI
13.62%
FI/BANKS/INSURANCE
0.55%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • SATCO CAPITAL MARKETS LTD. All rights reserved. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     290352